@junglejava1 Lets Go! $PHRM $PHRRF 🍀
New Investors Deck brings some clarity to todays Press Release and its CraZy market overreaction, on what actually was good News. IMHO
If anything, I feel it was a push by shorts and manipulators.
I believe this will bounce back hard, soon enough. 💸
Great buy here after the sell-off. ATH was near $1, now trading much lower with FDA approval in hand. 🚀
Partnership announcements could send this flying again. $PHRRF $PHRM
$PHRRF announced that the FDA has approved the Company's ketamine product, herein referred to as KETARx, on August 8th, 2025, for its indicated uses in surgical pain management.
https://t.co/QUBVOLHwfS
@cmac_lax_atx@hbossnia@FabioChianelli My sense is you'd deliver bad news into the weekend. Good news on a Monday morning is much better for an approval with the excitement imo
⬇️
PharmaTher Secures Key US Patent for #Ketamine in Amyotrophic Lateral Sclerosis (#ALS), Bolstering its Orphan Drug Designated Program and Targeting a Billion Dollar Market
Press release:
https://t.co/6mKZVhY7xu
$PHRRF $PHRM $PHRM.C